Agios Pharmaceuticals (NASDAQ:AGIO) reported Q1 2018 earnings this Morning, coming in at ($1.63) per share, beating Wall Street’s estimates of ($1.68) per Share. Revenue for the quarter came in at $8.80 million beating analyst estimates of $11.93 million Recent Insider Trading for Agios Pharmaceuticals (NASDAQ:AGIO)
- On 5/1/2018 David P Schenkein, CEO, sold 13,000 with an average share price of $83.04 per share and the total transaction amounting to $1,079,520.00.
- On 4/23/2018 Steven L Hoerter, Insider, sold 2,050 with an average share price of $85.95 per share and the total transaction amounting to $176,197.50.
- On 4/12/2018 Christopher Bowden, Insider, sold 2,000 with an average share price of $85.10 per share and the total transaction amounting to $170,200.00.
- On 4/5/2018 Scott Biller, Insider, sold 3,000 with an average share price of $75.20 per share and the total transaction amounting to $225,600.00.
- On 4/2/2018 David P Schenkein, CEO, sold 13,000 with an average share price of $77.72 per share and the total transaction amounting to $1,010,360.00.
- On 3/22/2018 Steven L Hoerter, Insider, sold 2,050 with an average share price of $84.65 per share and the total transaction amounting to $173,532.50.
Dividend History for Agios Pharmaceuticals (NASDAQ:AGIO)
Recent Trading for Agios Pharmaceuticals (NASDAQ:AGIO) Shares of Agios Pharmaceuticals closed the previous trading session at 83.25 up +0.83 1.01% with 83.25 shares trading hands.